Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06439901

Optimizing Bronchopulmonary Cancer Screening

Optimizing the Implementation of Bronchopulmonary Cancer Screening in the Ile de France Region (OPTI-DEPIST-MUT)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
500 (estimated)
Sponsor
Institut Curie · Academic / Other
Sex
All
Age
50 Years – 74 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to evaluate the feasibility of performing a first screening for bronchopulmonary cancer by thoracic scanner in a French cohort within a dedicated, effective and structured network in the pilot centers participating in the study.

Detailed description

The organization of bronchopulmonary cancer screening in the Ile de France region, within the Mutualists and its affiliated health centers, is based on a clear, simple and functional process: * Definition of eligibility criteria for screening, based on those of the NELSON study, * Referral and consultation by a health center physician trained in these criteria, * Referral and performance of a chest Computer Tomography Scanner (CTscan) according to the same recommendations, * Structured centralized reading and interpretation of CTscan images, * Referral to a multidisciplinary team (CITT), if bronchopulmonary cancer is suspected, * Referral to a tobacco unit in a health center for smokers who have not stopped smoking, * Organization of follow-up and continuation of the screening program.

Conditions

Interventions

TypeNameDescription
OTHERScreeningA first step to identify and recruit people eligible for screening,
OTHERInclusionA second step for inclusion of participants, with an online self-questionnaire and information, and an inclusion visit to the health center,
OTHERChest CTscan and follow-upA third step with an initial CTscan, with dual interpretation and appropriate management of participants, including follow-up care.

Timeline

Start date
2025-01-17
Primary completion
2032-01-17
Completion
2033-01-17
First posted
2024-06-03
Last updated
2025-02-03

Locations

8 sites across 1 country: France

Source: ClinicalTrials.gov record NCT06439901. Inclusion in this directory is not an endorsement.